foto london banner.jpg

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Transformational deal making: Oxford Biomedica

Given the recent announcement of Oxford Biomedica securing £50m loan fundin...

Read More

£25M Series C investment in the battle against Can...

Dr John Beadle, CEO of PsiOxus Therapeutics outlines what the investment wi...

Read More

Oxford AHSN’s role in developing special networks

Prof. Gary Ford CBE, talks through what OAHSN is doing to break down tradit...

Read More

Francois Martelet, CEO and his aim for NetScientif...

3 months into his tenure as CEO of NetScientific, the vastly experienced in...

Read More

Europe’s Largest Private Life Sciences Financing -...

Fresh from their record breaking £205m private finance raising, we talk to ...

Read More

Fundraising from one of the UK's leading investors

Newly appointed Chairman and CEO, Chris Yates discusses the potential of Ab...

Read More

Attracting investment from a leading EIS fund

We talk to CEO David Venables off the back of Synpromics securing £2.1m EIS...

Read More

ISSUE 7, 2015 Drugs & Dealers Magazine Released

Biotech and Money are pleased to announce the release of the latest Drugs &...

Read More

Add Your Response